Sri Haas Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 3.40 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.18 Cr
- Revenue Growth 48.34%
- Profit Growth 44.46%
- Ebitda 23.45%
- Net Worth 76.77%
- Total Assets 47.10%
About Sri Haas Life Sciences
Sri Haas Life Sciences Private Limited (SHLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 June 2018 (Six years and eight months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.40 M.
The company currently has active open charges totaling ₹8.18 Cr.
Mudunuru Sasikumar and Devi Kutcherlapati serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290TG2018PTC125040
- Company No.
125040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sri Haas Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mudunuru Sasikumar  | Managing Director | 12-Jun-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devi Kutcherlapati | Director | 23-Jul-2020 | Current |
Financial Performance of Sri Haas Life Sciences.
Sri Haas Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.34% increase. The company also saw a substantial improvement in profitability, with a 44.46% increase in profit. The company's net worth Soared by an impressive increase of 76.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Haas Life Sciences?
In 2023, Sri Haas Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.18 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 8.00 Cr
- Others : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Apr 2024 | Others | ₹1.82 M | Open |
| 05 Jul 2023 | Hdfc Bank Limited | ₹8.00 Cr | Open |
How Many Employees Work at Sri Haas Life Sciences?
Sri Haas Life Sciences has a workforce of 15 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Haas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Haas Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
